The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial

Cancer

Volumn 91, Issue 10, 2001, Pages 1949-1955

  Cohen, Lorenzo ^a,c   De Moor, Carl ^b   Amato, Robert J ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Depression; Mental health; Neoplasms; Optimism; Phase I trials

Indexed keywords

TUMOR VACCINE;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DISTRESS SYNDROME; FEMALE; HUMAN; KIDNEY CARCINOMA; MALE; MELANOMA; METASTASIS; PATIENT ATTITUDE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, RENAL CELL; DECISION MAKING; DEPRESSIVE DISORDER; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; MOTIVATION; PATIENT PARTICIPATION; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TEMPERAMENT; TEST ANXIETY SCALE; THERAPEUTICS;

EID: 0035873327     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010515)91:10<1949::AID-CNCR1218>3.0.CO;2-A     Document Type: Article

References (31)

1. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents
2. Therapeutic response in phase I trials of antineoplastic agents
3. Responses and toxic deaths in phase I clinical trials
4. Response rates, duration of response, and dose response effects in phase I studies of antineoplastics
5. Patient motivation and informed consent in a phase I study of an anticancer agent
6. Informed consent for phase I studies: Evaluation of quantity and quality of information provided to patients
7. Perceptions of cancer patients and their physicians involved in phase I trials
8. Ethical issues in phase I oncology research: A comparison of investigators and institutional review board chairpersons
9. Patients in phase I trials of anti-cancer agents in Japan: Motivation, comprehension and expectations
10. Phase I trials in cancer patients: Participants' perceptions
11. Expectations and experiences of patients with cancer participating in phase I clinical trials
12. Pessimism, age, and cancer mortality
13. Optimism and coping with a breast cancer symptom
14. Psychological distress and well-being in advanced cancer: The effects of optimism and coping
15. Optimism versus pessimism predicts the quality of women's adjustment to early breast cancer
16. How coping mediates the effect of optimism on distress: A study of women with early stage breast cancer
17. Psychological adjustment in breast cancer: Processes of emotional distress
18. Negative HW-specific expectations and AIDS-related bereavement as predictors of symptom onset in asymptomatic HW-positive gay men
19. Realistic acceptance as a predictor of decreased survival time in gay men with AIDS
20. Optimism, coping, psychological distress, and high-risk sexual behaviour among men at risk for acquired immunodeficiency syndrome (AIDS)
21. Adjustment to threatening events: A theory of cognitive adaptation
22. Illusions and well-being: A social psychological perspective on mental health
23. Psychological resources, positive illusions and health
24. Optimism is associated with mood, coping, and immune change in response to stress
25. Optimism, coping, and health: Assessment and implications of generalized outcome expectancies
26. The CES-D scale: A new self-report depression scale for research in the general population
27. The brief symptom inventory: An introductory report
28. Positive expectations predict health after heart transplantation
29. A phase I trial on the ethics of phase I trials